These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24919584)

  • 1. Oral anticoagulation and vitamin K deficiency.
    Eichinger S
    Hamostaseologie; 2014; 34(3):237-8. PubMed ID: 24919584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause].
    Fontana S; Zeerleder S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):477-80. PubMed ID: 10517112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normotest screenings and prophylactic oral administration for idiopathic vitamin K deficiency in infancy.
    Shirahata A; Nojiri T; Takaragi S; Horiuchi T; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1982 Jul; 45(4):867-75. PubMed ID: 7136473
    [No Abstract]   [Full Text] [Related]  

  • 6. An unexpected cause of macroscopic haematuria.
    Lubel JS; Burrell LM; Levidiotis V
    Med J Aust; 2005 Sep; 183(6):321-3. PubMed ID: 16167874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study.
    Buecking B; Eschbach D; Bliemel C; Oberkircher L; Struewer J; Ruchholtz S; Sachs UJ
    Thromb Res; 2014 Jan; 133(1):42-7. PubMed ID: 24196230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme.
    Prochaska JH; Coldewey M; Göbel S; Keller K; Hendelmeier M; Konstantinides S; Münzel T; Wild PS;
    Eur J Prev Cardiol; 2015 May; 22(5):622-8. PubMed ID: 24685605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of diffuse alveolar haemorrhage with acquired vitamin K deficiency.
    Drent M; Wessels S; Jacobs JA; Thijssen H
    Respiration; 2000; 67(6):697. PubMed ID: 11124658
    [No Abstract]   [Full Text] [Related]  

  • 10. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.
    Walenga JM; Drenth AF; Mayuga M; Hoppensteadt DA; Prechel M; Harder S; Watanabe H; Osakabe M; Breddin HK
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):325-31. PubMed ID: 18586683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of oral vitamin K effectively reverses oral anticoagulation with phenprocoumon during heart catheterisation.
    Ulrich S; Debrunner J; Stoll S; Rentsch K; Bachli EB
    Swiss Med Wkly; 2006 Oct; 136(43-44):691-5. PubMed ID: 17183431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conservative anticoagulation].
    Bischoff A
    MMW Fortschr Med; 2016 Mar; 158(4):16. PubMed ID: 27119861
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravesical haemorrhage: a rare late manifestation of vitamin K deficiency.
    Gürakan B; Yilmaz G; Ozbek N
    J Paediatr Child Health; 2000 Jun; 36(3):290. PubMed ID: 10960343
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency.
    Wong RS; Cheng G; Chan NP; Wong WS; NG MH
    Am J Hematol; 2006 Jan; 81(1):76. PubMed ID: 16369967
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin K and the older infant.
    Lukens JN
    Am J Dis Child; 1972 Nov; 124(5):639-40. PubMed ID: 5085476
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reversal of oral anticoagulation in intracranial hemorrhage].
    Bösel J; Steiner T
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2366-9. PubMed ID: 21082529
    [No Abstract]   [Full Text] [Related]  

  • 17. Late vitamin K deficiency bleeding: 16 cases reviewed.
    Doneray H; Tan H; Buyukavci M; Karakelleoglu C
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):529-30. PubMed ID: 17762526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin hypersensitivity due to gluten-sensitive enteropathy: a case study.
    Kwolek S; Deming P
    Clin Lab Sci; 2012; 25(2):78-80. PubMed ID: 22693776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.